Well, Bayers CEO deserves kudos for honesty and forthrightness if not for PR savvy. Marijn Dekkers recently told reporters that at an industry forum that "We did not develop this medicine (Nexavar) for Indians. We developed it for western patients who can afford it."
This comment arose as a result of India's government awarding a compulsory license for the medication to an generic competitor that promptly dropped market price by 80%. Dekker termed the goverment/regulatory action as "essentially theft." Masterfully stated if not exactly PC. Bayer confirmed the accuracy of the statements when asked. Dekker further elaborated that these were quick response statements to a question and that he had been "particularly frustrated" by the licensing action.
A patient advocacy group, Medecins Sans Frontieres (MSF) said on Friday that the Bayer chief's remarks summed up "everything that is wrong" with the multinational pharmaceutical industry. Bravo, Marijn! See The Economic Times story.
Posted by Bruce Lehr Jan 25th 2014.